z-logo
open-access-imgOpen Access
Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety
Author(s) -
Sharvesh Raj Seeruttun
Publication year - 2019
Publication title -
aims genetics
Language(s) - English
Resource type - Journals
ISSN - 2377-1143
DOI - 10.3934/genet.2019.3.64
Subject(s) - immune system , immunotherapy , cancer , cancer immunotherapy , immune checkpoint , immunology , medicine , cancer research , antigen , cancer cell , antibody , melanoma , ctla 4 , t cell

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here